LLYUS
Eli Lilly and Company · BVL:LLYUS
1,414.00 USD131.00 +10.21%
Eli Lilly and Company (BVL:LLYUS) last traded at 1,414.00 USD, up 10.21% on the day. Over the past year the stock is up 66.35%. Its 52-week range is 852.40 to 1,414.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open1,414.00
Day range1,414.00 – 1,414.00
52-week range852.40 – 1,414.00
Volume2
Average volume (10 days)41
Market cap1.33 T
P/E46.45
EPS (TTM)30.44
Dividend yield0.47%
Revenue (TTM)86.46 B
Employees50.00 K
Performance
+7.94%1 week
+19.32%1 month
+21.37%3 months
+65.88%6 months
+32.27%Year to date
+66.35%1 year
Technical rating
Strong buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
1,457.92 USD
The average 1-year price target, +3.11% from the last price. See the forecast
Latest headlines
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
- Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
- What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.